Lars Johan Erkell

491 total citations
22 papers, 426 citations indexed

About

Lars Johan Erkell is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lars Johan Erkell has authored 22 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lars Johan Erkell's work include Protease and Inhibitor Mechanisms (5 papers), Trace Elements in Health (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Lars Johan Erkell is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Trace Elements in Health (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Lars Johan Erkell collaborates with scholars based in Sweden, Germany and Italy. Lars Johan Erkell's co-authors include Volker Schirrmacher, Per‐Erik Olsson, Peter Kling, Peter Kille, Georg Brunner, Michael D. Kramer, Elard Jacob, Martin Hofmann‐Apitius, Robert Blakytny and Erik Walum and has published in prestigious journals such as FEBS Letters, European Journal of Biochemistry and Experimental Cell Research.

In The Last Decade

Lars Johan Erkell

22 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Johan Erkell Sweden 11 132 128 121 99 66 22 426
Jacob R. Hartman Israel 8 284 2.2× 65 0.5× 23 0.2× 23 0.2× 41 0.6× 9 419
Viviana De Rosa Italy 12 240 1.8× 152 1.2× 101 0.8× 109 1.1× 34 0.5× 29 599
Gang Dong United States 7 230 1.7× 147 1.1× 28 0.2× 35 0.4× 38 0.6× 8 504
Carol J. Oborn United States 16 481 3.6× 123 1.0× 84 0.7× 243 2.5× 39 0.6× 19 981
D G Roman United States 12 538 4.1× 81 0.6× 41 0.3× 180 1.8× 9 0.1× 14 904
Julie Hall United States 11 288 2.2× 85 0.7× 21 0.2× 42 0.4× 9 0.1× 14 552
Huilan Lin United States 14 467 3.5× 73 0.6× 24 0.2× 124 1.3× 21 0.3× 18 831
Kaori Ishihara Japan 9 200 1.5× 67 0.5× 211 1.7× 402 4.1× 8 0.1× 10 601
Lucie Larouche Canada 6 276 2.1× 43 0.3× 16 0.1× 23 0.2× 21 0.3× 7 360
Michael R. Rossi United States 12 211 1.6× 56 0.4× 24 0.2× 27 0.3× 11 0.2× 17 440

Countries citing papers authored by Lars Johan Erkell

Since Specialization
Citations

This map shows the geographic impact of Lars Johan Erkell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Johan Erkell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Johan Erkell more than expected).

Fields of papers citing papers by Lars Johan Erkell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Johan Erkell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Johan Erkell. The network helps show where Lars Johan Erkell may publish in the future.

Co-authorship network of co-authors of Lars Johan Erkell

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Johan Erkell. A scholar is included among the top collaborators of Lars Johan Erkell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Johan Erkell. Lars Johan Erkell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blakytny, Robert, Lars Johan Erkell, & Georg Brunner. (2006). Inactivation of active and latent transforming growth factor beta by free thiols: Potential redox regulation of biological action. The International Journal of Biochemistry & Cell Biology. 38(8). 1363–1373. 24 indexed citations
2.
Erkell, Lars Johan, et al.. (2000). Radiation and hypothermia: changes in DNA supercoiling in human diploid fibroblasts.. PubMed. 19(6B). 5307–11. 10 indexed citations
3.
Erkell, Lars Johan, et al.. (1999). Influence of Temperature on Radiation-Induced Inhibition of DNA Supercoiling. Radiation Research. 152(2). 137–137. 14 indexed citations
4.
Brunner, Georg, et al.. (1998). Sulfated Glycosaminoglycans Enhance Tumor Cell Invasionin Vitroby Stimulating Plasminogen Activation. Experimental Cell Research. 239(2). 301–310. 26 indexed citations
5.
Olsson, Per‐Erik, Peter Kling, Lars Johan Erkell, & Peter Kille. (1995). Structural and Functional Analysis of the Rainbow Trout (Oncorhyncus mykiss) Metallothionein-A Gene. European Journal of Biochemistry. 230(1). 344–349. 59 indexed citations
6.
Kramer, Michael D., Martin Hofmann‐Apitius, Lars Johan Erkell, et al.. (1991). Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Experimental Cell Research. 192(2). 453–459. 74 indexed citations
7.
Tibblin, S, et al.. (1989). Angiogenic Activity of Solid and Ascites-Transformed Syngeneic Murine Tumors. Medical Principles and Practice. 1(3). 147–153. 1 indexed citations
8.
Brunner, Georg, Jens Pohl, Lars Johan Erkell, Adriana Radler‐Pohl, & Volker Schirrmacher. (1989). Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene. Journal of Cancer Research and Clinical Oncology. 115(2). 139–144. 24 indexed citations
9.
Lichtner, Rosemarie B., Lars Johan Erkell, Volker Schirrmacher, & Garth L. Nicolson. (1989). Effects of RA 233 treatment on the adhesive, invasive and metastatic properties of 13762NF rat mammary tumor cells. Clinical & Experimental Metastasis. 7(2). 175–186. 4 indexed citations
10.
Brunner, Georg, et al.. (1989). Sulfated glycosaminoglycans accelerate the activation of PRO-uPA and plasminogen and stimulate in vitro invasion of tumor cells. Fibrinolysis and Proteolysis. 3. 6–6. 1 indexed citations
11.
Erkell, Lars Johan & Volker Schirrmacher. (1988). Quantitative in vitro assay for tumor cell invasion through extracellular matrix or into protein gels.. PubMed. 48(23). 6933–7. 53 indexed citations
12.
Erkell, Lars Johan, Walter Ryd, & B Hagmar. (1985). Purity and transplantation properties of tumor cell suspensions. Clinical & Experimental Metastasis. 3(1). 1–5. 2 indexed citations
13.
Walum, Erik, Alan C. Peterson, & Lars Johan Erkell. (1985). Photometric recording of cell viability using trypan blue in perfused cell cultures. Xenobiotica. 15(8-9). 701–704. 8 indexed citations
14.
Erkell, Lars Johan, et al.. (1982). Comments on the filter test for tumor cell deformability. 2(5). 260–267. 5 indexed citations
15.
Erkell, Lars Johan, Gianna Evelina De Medio, Kenneth Haglid, & G Porcellati. (1980). Increased activity of a phospholipid base‐exchange system by the differentiation of neoplastic cells from the nervous system. Journal of Neuroscience Research. 5(2). 137–141. 2 indexed citations
16.
Erkell, Lars Johan. (1980). Differentiation of Mouse Neuroblastoma Cells under Increased Oxygen Tension. Pathobiology. 48(5). 374–380. 9 indexed citations
17.
Erkell, Lars Johan & Erik Walum. (1979). Differentiation of cultured neuroblastoma cells by urea derivatives. FEBS Letters. 104(2). 401–404. 8 indexed citations
18.
Erkell, Lars Johan. (1977). Differences in membrane structure between suspended and attached mouse neuroblastoma cells. FEBS Letters. 77(2). 187–190. 11 indexed citations
19.
Edström, Å., Lars Johan Erkell, & Hans‐Arne Hansson. (1975). Reversal of morphological differentiation of mouse neuroblastoma cells by mitosis-inhibitors and anesthetics. Virchows Archiv B Cell Pathology. 19(1). 101–113. 11 indexed citations
20.
Erkell, Lars Johan, et al.. (1974). Effects of mitosis inhibitors and anesthetics on differentiated mouse neuro blastoma cells. 91(3). 48–49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026